TSHおよび促進型TSH受容体抗体による甲状腺細胞増殖制御におけるPI3K/PDK-1およびS6K1の役割 : サマリー
スポンサーリンク
概要
- 論文の詳細を見る
- 2002-02-01
著者
-
Cho Bo
Department Of Nuclear Medicine Seoul National University College Of Medicine
-
Cho Bo
Division Of Endocrinology And Metabolism Department Of Internal Medicine Seoul National University C
-
Shong Minho
Department Of Internal Medicine School Of Medicine Chungnam National University
関連論文
- The clinical impact of ^F-FDG PET in papillary thyroid carcinoma with a negative ^I whole body scan : a single-center study of 108 patients
- Early Changes in Biochemical Markers of Bone Turnover Predict Bone Mineral Density Response to Antiresorptive Therapy in Korean Postmenopausal Women with Osteoporosis
- Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinoma
- A New Point Mutation(3426, A to G) in Mitochondrial NADH Dehydrogenase Gene in Korean Disbetic Patients Whici Mimics 3243 Mutation by Restriction Fragment Length Polymorphism Pattern
- CLINICAL IMPLICATIONS OF EPITOPE HETEROGENEITY OF THYROID STIMULATING ANTIBODIES
- TSHおよび促進型TSH受容体抗体による甲状腺細胞増殖制御におけるPI3K/PDK-1およびS6K1の役割 : サマリー